Investors Watch List: Capnia, Inc. (NASDAQ:CAPN), Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI), JA Solar Holdings Co., Ltd. (NASDAQ:JASO), Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Capnia, Inc. (NASDAQ:CAPN) belongs to Healthcare sector. Its weekly performance is 11.74%. On last trading day company shares ended up $2.95. Capnia, Inc. (NASDAQ:CAPN) distance from 50-day simple moving average (SMA50) is -27.48%. On 6 July, Capnia, Inc. (NASDAQ:CAPN) announced that it has signed a definitive agreement to buy out CoSense® royalty rights originally held by BioMedical Drug Development, Inc. (BDDI). Under terms of the agreement, all royalties on future sales of CoSense, and related payments, due to BDDI or its affiliates under the Capnia Purchase Agreement are eliminated, providing Capnia with 100% of the financial interest in the product.

Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) shares advanced 0.71% in last trading session and ended the day at $1.41. RCPI return on assets is -530.10%. Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) quarterly performance is -53.00%.On 1 July, Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) said that, Oracle is using Chattanooga’s Rock/Creek for the launch of a new platform called Oracle Commerce Cloud, which aims to take pressure off retailers who want online stores but not the hassle of maintaining them.

JA Solar Holdings Co., Ltd. (NASDAQ:JASO) belongs to Technology sector. Its net profit margin is 4.00% and weekly performance is 1.30%. On last trading day company shares ended up $7.80. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) distance from 50-day simple moving average (SMA50) is -13.06%.On 6 July, JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced its standard modules successfully passed the Class A fire test in accordance with UL1703 standard for Type 1 modules. During the test, all six sets of BOM used for JA Solar’s type-1 modules passed the UL Class A fire test conducted by Intertek, making JA Solar the first company mass producing PV modules in China to pass the test.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) ended the last trading day at $11.59. Company weekly volatility is calculated as 4.38% and price to cash ratio as 2.97. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) showed a weekly performance of 10.07%. Robert W. Baird initiated coverage on shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) in a research note released on Wednesday morning. The firm issued an outperform rating and a $15.00 target price on the medical device company’s stock.

Leave a Reply

Your email address will not be published. Required fields are marked *